People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncocyte Corp | — | Biotechnology | Series B | $83.0M | $119.2M | 2021 |
| N-of-One, Inc. | — | Other Health Care | Series A | $12.7M | $141.3M | 2011 |
Jennifer Levin Carter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jennifer Levin Carter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael D West | 1 | 6 |
| Alfred D Kingsley | 1 | 6 |
| Peter McKay | 1 | 4 |
| Mitch Levine | 1 | 4 |
| Joseph Wagner | 1 | 3 |
| Robert W Peabody | 1 | 3 |
| Mark Pottle | 1 | 3 |
| Andrew Arno | 1 | 3 |
| Jennifer Carter | 1 | 2 |
| Melissa Cruz | 1 | 2 |
| Louis Silverman | 1 | 2 |
| Ronald A Andrews | 1 | 2 |
| Douglas T. Ross | 1 | 2 |
| James Liu | 1 | 2 |
| Andrew W. Arno | 1 | 2 |
| Russell Skibsted | 1 | 2 |
| Ying Lee | 1 | 1 |
| Joe Levin O'Connor | 1 | 1 |
| Karen B. Chapman | 1 | 1 |
| Joseph O'Connor | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.